Jennifer Han, MD, Pediatric Hematologist-Oncologist at IHTC

Get to know Dr. Han

Dr. Han is a Pediatric Hematologist-Oncologist at the Indiana Hemophilia and Thrombosis Center (IHTC).

Education & Training

Loma Linda University School of Medicine | MD

University of New Mexico School of Medicine | Pediatric Residency

University of California, San Diego/Rady Children's Hospital of San Diego | Pediatric Hematology-Oncology Fellowship

University of California, San Diego/Rady Children's Hospital of San Diego | Pediatric Hemostasis & Thrombosis Fellowship

Certifications & Licensure

American Board of Pediatrics

Societies & Honors

National Hemophilia Foundation | Takeda Clinical Fellowship Grant Award

American Society of Hematology | Medical Educators Institute Recipient

Haemophilia Academy Awardee

Hemostasis and Thrombosis Research Society | Trainee Workshop Invitee

International Pediatric Stroke Organization

International Society of Thrombosis and Haemostasis

Association of Medical School Pediatric Department Chairs | Frontiers in Science Invitee

Quality Improvement Methodology Fellow Award, Resident Excellence in Teaching Award, Senior Resident Award

Expertise & Special Interests

Pediatric Thrombosis

Neonatal & Pediatric Stroke

Hemophilia

von Willebrand Disease (VWD)

Rare Bleeding Disorders

Publications

Molecular and phenotypic diversity of CBL-mutated juvenile myelomonocytic leukemia. Haematologica. Jan 1;107(1):178-186. doi: 10.3324/haematol.2020.270595. 2022. Hecht A, Meyer J, Behnert A, Wong E, Chehab F, Olshen A, Hechmer A, Aftandilian C, Bhat R, Choi SW, Chonat S, Farrar JE, Fluchel M, Frangoul H, Han JH, Kolb EA, Kuo DJ, MacMillan ML, Maese L, Maloney KW, Narendran A, Oshrine B, Schultz KR, Sulis ML, Van Mater D, Tasian SK, Hofmann WK, Loh ML, Stieglitz E.

Primary Presentation of Pediatric Hematopoietic Malignancy in the Temporal Bone: Case Report and Review of the Literature. Ear Nose Throat J. Nov; 100(9):NP407-NP412. 2021. Dorneden AM, Husen BS, Han JH, Magdaleno Y, Meiklejohn DA.

Dynamic re-immunization of off-treatment childhood cancer survivors: An implementation feasibility study. PLoS One. Feb 1;13(2):e0191804. doi: 10.1371/journal.pone.0191804. eCollection 2018. Han JH, Harmoney KM, Dokmeci E, Torrez J, Chavez CM, Cordova de Ortega L, Kuttesch JF, Muller M, Winter SS.

A short interview with Dr. Han

What inspires you about your work?
I’m inspired by my patients and families and feel honored that I am able to get to truly know them and help them through a time that is likely one of the most difficult and vulnerable in their lives. I’m inspired by the team members at IHTC who strive to serve our patients. And I’m inspired by our center that continues to carry out the most advanced therapies to improve the outcomes and lives of our patients.

What do you hope to accomplish for patients?
My utmost hope for my patients is that they are happy and live more fulfilling lives. I hope that patients and families know that I am fully committed to taking care of them and will provide the best possible care. This includes striving for the most advanced and state-of-the-art treatment, establishing a meaningful and honest relationship with them that goes beyond their medical condition, and for my patients to know that they are truly the most important member of our team.

What do you like about IHTC and its approach to care?
I’ve been humbled by all the various and different roles each staff member carries out every day for our patients, families, and community. Babies, kids, and teenagers with pediatric blood disorders require a unique expertise in caring for them, and here at IHTC, I’ve greatly appreciated the outstanding care provided by IHTC’s staff members.